Credit Suisse Ag Grifols Sa Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$6.65 - $10.69 $11,970 - $19,242	1,800 Added 11.84%	17,000 $125,000
Q4 2022 Feb 13, 2023	SELL	$5.96 - $8.53 $892,808 - $1.28 Million	-149,800 Reduced 90.79%	15,200 $129,000
Q2 2022 Aug 12, 2022	BUY	$10.6 - $13.28 $230,020 - $288,176	21,700 Added 15.14%	165,000 $1.96 Million
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $1.27 Million - $1.56 Million	-122,431 Reduced 46.07%	143,300 $1.67 Million
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $950,785 - $1.42 Million	93,123 Added 53.95%	265,731 $2.98 Million
Q3 2021 Nov 12, 2021	SELL	$14.07 - $17.3 $2.49 Million - $3.07 Million	-177,273 Reduced 50.67%	172,608 $2.52 Million
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $3.56 Million - $4.06 Million	214,475 Added 158.39%	349,881 $6.07 Million
Q1 2021 May 14, 2021	BUY	$15.15 - $19.78 $393,172 - $513,330	25,952 Added 23.71%	135,406 $2.34 Million
Q4 2020 Feb 12, 2021	BUY	$16.86 - $19.67 $915,717 - $1.07 Million	54,313 Added 98.5%	109,454 $2.02 Million
Q3 2020 Nov 13, 2020	BUY	$15.4 - $20.16 $849,171 - $1.11 Million	55,141 New	55,141 $956,000
Q2 2020 Aug 12, 2020	SELL	$18.24 - $21.45 $241 Million - $284 Million	-13,239,050 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$16.28 - $25.63 $18.9 Million - $29.8 Million	1,163,476 Added 9.63%	13,239,050 $267 Million
Q4 2019 Feb 12, 2020	SELL	$19.57 - $23.52 $1.65 Million - $1.98 Million	-84,141 Reduced 0.69%	12,075,574 $281 Million
Q3 2019 Nov 12, 2019	BUY	$19.85 - $22.76 $237 Million - $272 Million	11,959,365 Added 5969.24%	12,159,715 $244 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $3.52 Million - $4.23 Million	200,350 New	200,350 $4.23 Million
Q4 2018 Feb 13, 2019	SELL	$17.44 - $21.53 $155 Million - $192 Million	-8,902,530 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$19.97 - $21.96 $20.3 Million - $22.3 Million	-1,015,345 Reduced 10.24%	8,902,530 $190 Million
Q2 2018 Aug 14, 2018	SELL	$20.16 - $24.68 $15.9 Million - $19.5 Million	-790,647 Reduced 7.38%	9,917,875 $213 Million
Q1 2018 May 15, 2018	SELL	$20.31 - $24.95 $4.73 Million - $5.81 Million	-232,708 Reduced 2.13%	10,708,522 $227 Million
Q4 2017 Feb 14, 2018	SELL	$20.99 - $23.89 $11.1 Million - $12.7 Million	-529,967 Reduced 4.62%	10,941,230 $251 Million
Q3 2017 Nov 14, 2017	SELL	$20.07 - $21.89 $17.8 Million - $19.4 Million	-885,398 Reduced 7.17%	11,471,197 $251 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,356,595	12,356,595 $261 Million

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

Capital World Investors Los Angeles, CA

21M
Shares

$165 Million
0.03% of portfolio
Brandes Investment Partners, LP La Jolla, CA

19.9M
Shares

$156 Million
2.11% of portfolio
Permian Investment Partners, LP New York, NY

12.3M
Shares

$96.8 Million
16.06% of portfolio
Black Creek Investment Management Inc. Toronto, A6

11.1M
Shares

$87.2 Million
3.5% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

10.7M
Shares

$84.2 Million
0.05% of portfolio

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account